Workflow
Why Is FMC (FMC) Up 0.7% Since Last Earnings Report?
FMC FMC (US:FMC) ZACKS·2025-08-29 16:37

Core Insights - FMC's earnings for Q2 2025 were reported at 53 cents per share, a decrease from $2.35 in the same quarter last year, but adjusted earnings per share of 69 cents exceeded the Zacks Consensus Estimate of 59 cents [2][3] - Revenues for the quarter reached approximately $1.05 billion, reflecting a 1.2% increase year-over-year and surpassing the Zacks Consensus Estimate of $965.4 million [2][3] Revenue Drivers - The increase in revenues was primarily driven by a 6% rise in volume, although prices fell by 3%, largely due to reductions in specific "cost-plus" contracts [3] - Foreign exchange rates negatively impacted results by 1% [3] Regional Sales Performance - North America: Sales decreased by 5% year-over-year to $321 million, influenced by reduced volumes in Canada despite strong growth in the U.S. [4] - Latin America: Sales increased by 1% year-over-year to $310 million, benefiting from new active ingredients, surpassing the consensus estimate [5] - Asia: Revenues declined by 17% year-over-year to $159 million, missing the consensus estimate due to lower pricing and reduced volume [5] - EMEA: Experienced a significant 29% year-over-year sales increase to $260 million, driven by volume increases in herbicides and branded products, exceeding the consensus estimate [6] Financial Position - At the end of the quarter, FMC had cash and cash equivalents of $438.2 million and long-term debt of approximately $3.27 billion [7] Guidance - FMC expects full-year revenues (excluding India) to range between $4.08 billion and $4.28 billion, indicating a 2% decline at the midpoint compared to 2024 [8] - Adjusted EBITDA is forecasted between $870 million and $950 million, suggesting 1% growth at the midpoint [8] - Adjusted earnings per share are projected to be between $3.26 and $3.70, indicating no change at the midpoint year-over-year [8] Market Sentiment - There has been an upward trend in fresh estimates for FMC, with the stock currently holding a Zacks Rank 3 (Hold), indicating expectations for an in-line return in the coming months [10][12]